Inhibitors Targeting RIPK1/RIPK3: Old and New Drugs
Author:
Funder
Flemish Government
Research Foundation Flanders
Ghent University
Foundation against Cancer
VIB
Foundation Against Cancer
Publisher
Elsevier BV
Subject
Pharmacology,Toxicology
Reference106 articles.
1. Targeting RIPK1,2,3 to combat inflammation;Bullock;Oncotarget,2015
2. Receptor-interacting protein (RIP) kinase family;Zhang;Cell. Mol. Immunol.,2010
3. RIP kinases: key decision makers in cell death and innate immunity;Humphries;Cell Death Differ.,2015
4. Mechanisms of RIPK3-induced inflammation;Shlomovitz;Immunol. Cell Biol.,2017
5. DAI/ZBP1 recruits RIP1 and RIP3 through RIP homotypic interaction motifs to activate NF-kappaB;Rebsamen;EMBO Rep.,2009
Cited by 126 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Structure-based discovery of a 4,5-Dihydropyrazole-cored PET ligand for imaging of receptor-interacting serine/threonine-protein kinase 1 (RIPK1) in the brain;European Journal of Medicinal Chemistry;2024-12
2. Preclinical Evaluation of Dihydropyrazole-Cored Positron Emission Tomography (PET) Ligands for Imaging of Receptor-Interacting Serine/Threonine Protein Kinase 1 (RIPK1) in the Brain;Journal of Medicinal Chemistry;2024-09-11
3. Recognition of necroptosis: From molecular mechanisms to detection methods;Biomedicine & Pharmacotherapy;2024-09
4. Intricate interplay between cell metabolism and necroptosis regulation in metabolic dysfunction-associated steatotic liver disease: A narrative review;Metabolism;2024-09
5. Blockade of IKK signaling induces RIPK1-independent apoptosis in human macrophages;PLOS Pathogens;2024-08-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3